Skip to content
Predictive-modifying therapy in patients with coronary artery disease (IHD): how to optimize treatment?
Diaphragmatic hernia: mechanisms of formation, clinic, treatment tactics
Experience of using pantoprazole in the complex therapy of diseases of the digestive tract of different age groups
Experience of using pantoprazole (Ulsepan) and a combined synbiotic (Opefera) in the complex therapy of children with gastroesophageal reflux disease and gastroduodenitis
Modern approaches to the treatment and prevention of gastrointestinal bleeding associated with NSAID gastropathy and stress ulcers
Ulsepan (pantoprazole) as an effective means of preventing erosive and ulcerative lesions of the gastroduodenal zone in patients during surgical interventions on the organs of the gastrointestinal tract
Drug prevention and treatment of gastropathies associated with the use of non-steroidal anti-inflammatory drugs
Selecting the Optimal Proton Pump Inhibitor for Patients with Coronary Artery Disease Who Require Dual Antiplatelet Therapy
Results of a multicenter study of the effectiveness of Helicobacter pylori eradication, carried out in accordance with the recommendations of the Maastricht Consensus V
The use of pantoprazole in the prevention of NSAID gastropathy
ULSEPAN: pantoprazol 40 mg
Username or email address
Lost your password?